Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Rachel Cohrs Zhang - Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
Bloomberg

The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd. As part of the deal, the companies will provide discounts…

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
GlobeNewswire

Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

newsweek.com - Gabe Whisnant - Donald Trump announces pharma deal: List of drugs getting prices reduced
Donald Trump announces pharma deal: List of drugs getting prices reduced
Newsweek

President Donald Trump on Monday announced agreements with nine additional drug manufacturers as part of his administration's effort to lower prescription drug costs. The agreements are part of the administration's 'Most Favored Nation' (MFN) drug…

yahoo.com - Exec-Edge - Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Yahoo!

Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of a rescue, but there is more to this story than what meets the eye. Investors glancing at the stock chart may miss…

seekingalpha.com - Pratyush Thakur - PMV Pharma announces proposed public offering (PMVP:NASDAQ)
PMV Pharma announces proposed public offering (PMVP:NASDAQ)
Seeking Alpha

PMV Pharmaceuticals () said on Monday it launched an underwritten public offering of common stock and accompanying warrants. The company may also offer pre-funded warrants to certain investors in lieu of common stock, along with accompanying…

seekingalpha.com - ALLKA Research - Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs (NYSEARCA:XLV)
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs (NYSEARCA:XLV)
Seeking Alpha

Nine of the 16 Big Pharma stocks covered in this article set new 52-week highs during August, reflecting strong momentum across the sector. Also, the rally has been driven by strong Q2 results, as well as Wall Street's growing shift toward…

econotimes.com - Riza Dagoc - Trump Secures Drug Pricing Deals With Nine Pharma Companies
Trump Secures Drug Pricing Deals With Nine Pharma Companies
EconoTimes

President Donald Trump announced new drug pricing agreements with nine pharmaceutical companies on Monday, expanding his administration's campaign to lower prescription drug costs for Americans. The agreements involve Astellas, BeOne Medicines…

thehindu.com - Pti - India calls for more predictable regulatory environment in Brazil to boost pharma exports
India calls for more predictable regulatory environment in Brazil to boost pharma exports
The Hindu

India has called for a more predictable regulatory environment in Brazil to boost exports of pharmaceutical goods, the Commerce Ministry said on Monday (August 31, 2026). The issue came up for discussion during the eighth meeting of the…

newswire.ca - Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
CNW

Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership HERZLIYA, Israel and CALGARY, Alberta, Aug. 31, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ('Innocan' or the 'Company'), today reported today 2026…

thehindubusinessline.com - Sun Pharma signs US MFN pricing agreement for Medicaid programmes
Sun Pharma signs US MFN pricing agreement for Medicaid programmes
BusinessLine

India's Sun Pharmaceutical Industries is among nine drugmakers that have signed an agreement with the United States government to extend “Most Favoured Nation” (MFN) pricing in America. The company said it would extend MFN pricing to…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Trading Up 7.3% - Here's Why
Ascendis Pharma A/S (NASDAQ:ASND) Trading Up 7.3% - Here's Why
MarketBeat

Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) rose 7.3% during trading on Monday. The company traded as high as $266.17 and last traded at $266.06. Approximately 172,528 shares changed hands during trading, a decline of 74% from the…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 6% - Should You Sell?
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 6% - Should You Sell?
MarketBeat

Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) fell 6% on Monday. The stock traded as low as $17.19 and last traded at $17.1850. 2,433 shares traded hands during mid-day trading, a decline of 64%…

marketbeat.com - Headlands Technologies LLC Invests $5.09 Million in Royalty Pharma PLC $RPRX
Headlands Technologies LLC Invests $5.09 Million in Royalty Pharma PLC $RPRX
MarketBeat

Headlands Technologies LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 90,729 shares of the biopharmaceutical…

rediff.com - Rediff News - The big losers in the markets today
The big losers in the markets today
Rediff.com

Among the 30 Sensex firms, Adani Ports fell the most by 4.11 per cent. Index major HDFC Bank reversed early gains to close down by 1.53 per cent as its CEO and Managing Director Sashidhar Jagdishan announced that he will opt for reappointment after…

smh.com.au - Staff reporters - CSL signs deal with Trump administration to slash prices for its medicines
CSL signs deal with Trump administration to slash prices for its medicines
The Sydney Morning Herald

Australia's largest pharma company CSL said it has signed agreements with the Trump administration to lower the cost of its medicines in the United States as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals…

Receive a Daily briefing on Pharma Industry News

Get Started